Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

eXoZymes, Inc. (EXOZ)

13.53
+1.74
+(14.76%)
At close: April 23 at 4:00:01 PM EDT
13.53
0.00
(0.00%)
After hours: April 23 at 4:05:07 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for EXOZ

Recent News: EXOZ

View More
Bringing clarity and precision to the cell-free space by introducing exozymes

Bringing clarity and precision to the cell-free space by introducing exozymes
GlobeNewswire 2 days ago

New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI Founder & CEO Dan O'Toole (ARAI)
ACCESS Newswire 9 days ago
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
GlobeNewswire 13 days ago
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
GlobeNewswire 21 days ago
eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes Provides Fourth Quarter and Full Year 2024 Update
GlobeNewswire 21 days ago
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
GlobeNewswire 28 days ago
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce
ACCESS Newswire last month
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
GlobeNewswire last month
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
GlobeNewswire 2 months ago
Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)

Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)
Simply Wall St. 2 months ago
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
GlobeNewswire 2 months ago
View More

Related Tickers

CUE Cue Biopharma, Inc.
0.8363
+6.85%
 
1OT.F Ovid Therapeutics Inc.
0.1960
-5.77%
 
RXK3.F SELLAS Life Sciences Group, Inc.
1.1760
+8.89%
 
LTI0.F Aptose Biosciences Inc. R
2.0200
+1.00%
 
1VT.MU Viking Therapeutics Inc
22.37
+7.65%
 
GOVXW GeoVax Labs, Inc.
0.0300
-0.33%
 
APTOF Aptose Biosciences Inc.
2.3100
-6.48%
 
CLVLY Clinuvel Pharmaceuticals Limited
7.10
0.00%
 
BINV.ST BioInvent International AB (publ)
29.10
+3.19%
 
WHWK Whitehawk Therapeutics, Inc.
1.5400
0.00%